P2B-013

Sarcoma Oncology Center (Santa Monica, CA) › P2B-013

P2B-013

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Sarcoma Oncology Center (Santa Monica, CA) · Dr. Reyes
consented 2012-06-22

completed

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 3 thrombocytopenia with onset in cycle 1 (2012-07-09); assessed as related to study drug (probable); resolved 2012-07-20.

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.